LVIS Corp launches FDA approved NeuroMatch Elite

June 10, 2025

LVIS Corp announced the upcoming U.S. release of NeuroMatch Elite.

NeuroMatch Elite launches with two capabilities - Seizure Source Localization and Spike Source Localization. This technology goes beyond traditional EEG analysis. NeuroMatch Elite offers precise seizure and spike source localization, which allows clinicians to accurately pinpoint the origin and network of abnormal brain activity in 3D, down to individual seizures or spikes. NeuroMatch Elite offers high-fidelity, non-invasive mapping tools directly within a clinicians existing workflow.

Physicians will be able to:
- Visualize seizure and spike origins on a dynamic 3D brain model
- Track brain network dynamics per second or across entire seizure events
- Compare multiple seizure events side-by-side
- Overlay findings onto established Brain Atlases for deeper anatomical context

Visit LVIS for more news